720. Efficacy of Fosfomycin for Injection (FOS) vs. Piperacillin–Tazobactam (PIP-TAZ) in Adults with Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): ZEUS Study Outcomes in Patients With Reduced Study Drug Susceptibility

BACKGROUND: FOS is being pursued for US registration in cUTI/AP. Safety and efficacy of FOS vs. PIP-TAZ were demonstrated in the noninferiority ZEUS trial in hospitalized patients with cUTI/AP. Although FOS resistance has been observed in several in vitro studies, resistance rates in clinical settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaye, Keith S, Das, Anita F, Eckburg, Paul B, Gelone, Steven P, Schranz, Jennifer, Ellis-Grosse, Evelyn J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811111/
http://dx.doi.org/10.1093/ofid/ofz360.788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811111/
http://dx.doi.org/10.1093/ofid/ofz360.788

Ejemplares similares